Drugs & Targets FDA fast tracks targeted breast cancer immunotherapy Bria-IMT April 15, 2022Vol.48 No.15
Drugs & Targets City of Hope validates Curate Cell Processing System for CAR T-cell therapy April 08, 2022Vol.48 No.14
Drugs & Targets C2i Genomics launches C2inform MRD test for distributed cancer monitoring in Europe April 08, 2022Vol.48 No.14
Drugs & Targets EU CHMP adopts positive opinion for Keytruda plus chemo ± bevacizumab in persistent, recurrent, or metastatic cervical cancer expressing PD-L1 (CPS ≥1) April 01, 2022Vol.48 No.13
Drugs & Targets EU CHMP adopts positive opinion for Cabometyx in radioactive iodine-refractory differentiated thyroid cancer April 01, 2022Vol.48 No.13
Drugs & Targets CHMP adopts positive opinion for Kymriah in relapsed or refractory follicular lymphoma April 01, 2022Vol.48 No.13
Drugs & Targets Thermo Fisher Scientific’s CE-IVD marked next-gen sequencing instrument available for use in clinical labs April 01, 2022Vol.48 No.13
Drugs & Targets Paige launches AI software to enable accurate and efficient detection of breast cancer metastases in lymph nodes April 01, 2022Vol.48 No.13
Drugs & Targets FDA approves Opdualag for unresectable or metastatic melanoma March 25, 2022Vol.48 No.12
